We are live on ! Find out more
CRL icon

Charles River Laboratories
CRL

612 hedge funds and large institutions have $10.7B invested in Charles River Laboratories in 2023 Q2 according to their latest regulatory filings, with 67 funds opening new positions, 252 increasing their positions, 203 reducing their positions, and 73 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 252 | Existing positions reduced: 203

5% more capital invested

Capital invested by funds: $10.3B → $10.7B (+$474M)

0.21% less ownership

Funds ownership: 100.16% → 99.94% (-0.21%)

8% less first-time investments, than exits

New positions opened: 67 | Existing positions closed: 73

1% less funds holding

Funds holding: 620 → 612 (-8)

16% less call options, than puts

Call options by funds: $29.3M | Put options by funds: $34.8M

17% less funds holding in top 10

Funds holding in top 10: 6 → 5 (-1)

Holders
612
Holders Change
-8
Holders Change %
-1.29%
% of All Funds
9.61%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
67
Increased
252
Reduced
203
Closed
73
Calls
$29.3M
Puts
$34.8M
Net Calls
-$5.51M
Net Calls Change
-$16.3M

Top Buyers

1
BlackRock
BlackRock
New York
+$81.8M
2
AI
Ariel Investments
Illinois
+$72.6M
3
ClearBridge Investments
ClearBridge Investments
New York
+$68.3M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$50.8M
5
MBI
Montrusco Bolton Investments
Quebec, Canada
+$43.7M

Top Sellers

1
Marshall Wace
Marshall Wace
United Kingdom
-$105M
2
Viking Global Investors
Viking Global Investors
Connecticut
-$79.5M
3
JSP
Jackson Square Partners
California
-$62.2M
4
William Blair Investment Management
William Blair Investment Management
Illinois
-$60M
5
FAM
Fred Alger Management
New York
-$44.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Two Sigma Investments
251
Two Sigma Investments
New York
$1.58M -$99.5K -500 -6%
EDRH
252
Edmond de Rothschild Holding
Switzerland
$1.55M -$238K -1,194 -14%
MOACM
253
Mutual of America Capital Management
New York
$1.55M +$15.5K +78 +1%
CIBC Asset Management
254
CIBC Asset Management
Ontario, Canada
$1.53M -$13.5K -68 -0.9%
ECM
255
Element Capital Management
New York
$1.49M +$71K +357 +5%
X
256
Xponance
Pennsylvania
$1.48M -$957K -4,811 -41%
CCM
257
Community Capital Management
Florida
$1.47M +$99.5K +500 +8%
AGP
258
Artia Global Partners
Florida
$1.45M – – –
VPIM
259
Vanguard Personalized Indexing Management
California
$1.39M +$22.7K +114 +2%
YCM
260
Yousif Capital Management
Michigan
$1.38M +$55.1K +277 +4%
PGCM
261
Prescott Group Capital Management
Oklahoma
$1.37M +$398K +2,000 +44%
SAM
262
Silvercrest Asset Management
New York
$1.33M +$223K +1,123 +22%
Pacer Advisors
263
Pacer Advisors
Pennsylvania
$1.3M +$481K +2,417 +64%
SG Americas Securities
264
SG Americas Securities
New York
$1.28M +$421K +2,114 +53%
CNB
265
Czech National Bank
Czech Republic
$1.27M +$12.9K +65 +1%
BF
266
BOK Financial
Oklahoma
$1.27M +$10.7K +54 +0.9%
WR
267
WD Rutherford
Oregon
$1.27M +$7.96K +40 +0.7%
CGH
268
Crossmark Global Holdings
Texas
$1.27M -$8.36K -42 -0.7%
CWM
269
CIBC World Markets
New York
$1.26M +$683K +3,435 +134%
CAN
270
Cetera Advisor Networks
California
$1.26M +$31.8K +160 +3%
SPIA
271
Steward Partners Investment Advisory
New York
$1.23M +$86.2K +433 +8%
CB
272
Commerce Bank
Missouri
$1.22M -$8.75K -44 -0.8%
TFP
273
Tilia Fiduciary Partners
North Carolina
$1.21M +$167K +837 +17%
ETCM
274
Evolutionary Tree Capital Management
Virginia
$1.19M +$796 +4 +0.1%
NAM
275
Nissay Asset Management
Japan
$1.12M -$7.16K -36 -0.7%
9 10
11
12 13

CRL Hedge Fund Activity: Q2 2023 in Review

612 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q2 2023, worth a combined $10.7B — up 4.6% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 73 funds closed out of CRL and 67 opened new positions — a net loss of 6 holders — while 203 trimmed existing stakes and 252 added.

The largest buyer was BlackRock, adding an estimated $81.8M. The largest seller was Marshall Wace, cutting an estimated $105M.

  • 612 institutional investors held Charles River Laboratories (CRL) as of Q2 2023, down from 620 in Q1 2023.
  • Funds reported $10.7B of Charles River Laboratories stock for Q2 2023, up 4.6% quarter-over-quarter.
  • 67 funds opened new Charles River Laboratories positions in Q2 2023 and 73 closed out, a net change of -6 holders.
  • The largest Charles River Laboratories buyer in Q2 2023 was BlackRock, an estimated $81.8M added.
  • The largest Charles River Laboratories seller in Q2 2023 was Marshall Wace, an estimated $105M sold.

Based on aggregated 13F filings for Q2 2023.